XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash Flows from Operating Activities    
Net loss $ (6,506,774) $ (6,405,280)
Net loss from discontinued operations (767,026)
Net loss from continuing operations (6,506,774) (5,638,254)
Adjustments to reconcile net loss to net cash provided/(used) by operating activities:    
Depreciation and amortization 2,158,938 3,208,933
Gain/(loss) on disposal of property & equipment 457 465,029
Amortization of right-of-use assets 352,691
Change in allowance for inventory obsolescence 726,824 25,469
Change in allowance for doubtful accounts 126 236,113
Share-based compensation 167,312 108,324
Interest expense paid in equity shares 2,505,924 1,253,516
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Accounts receivable 1,654,383 1,283,756
Accounts receivable - related party 5,510 (50,904)
Inventory (2,111,277) (175,159)
Prepaid expenses and other curent asstets 242,698 (719,271)
Other assets (1,017,337) (1,135,190)
Other liabilities (117,667) 354,332
Accounts payable (1,205,851) 19,660
Accounts payable - related party 155,600
Deposits from customers 2,003 9,390
Accrued expenses 938,132 2,367,665
Deferred revenue (99,354) 109,493
Income taxes payable 75,724 (153,734)
Net cash provided by operating activities - continuing operations (2,227,538) 1,724,768
Net cash provided by operating activities - discontinued operations 1,636,714
Net cash provided/(used) by operating activities (2,227,538) 3,361,482
Cash Flows from Investing Activities    
Net change in self-insured benefit deposits (246,154) (468,870)
Purchase of property and equipment (4,541,537) (1,525,998)
Purchase of marketable securities (1,366,009)
Investment in related party (500,000)
Net cash used by investing activities - continuing operations (6,653,700) (1,994,868)
Net cash used by investing activities - discontinued operations (119,482)
Net cash used by investing activities (6,653,700) (2,114,350)
Cash Flows from Financing Activities    
Proceeds from notes payable 4,485,000 1,100,000
Payments on notes payable (726,640) (264,560)
Proceeds on bank loans 5,947,101
Payments on bank loans (224,196) (1,453,506)
Proceeds from securities purchase agreements 12,462,648
Expenses on securities purchase agreements (840,728)
Proceeds from at-the-market offerings 490,237
Expenses on at-the-market offerings (18,323)
Proceeds from the issuance of Series B Preferred Stock 500,000
Expenses from the issuance of Series B Preferred Stock (25,000)
Settlement of Series B Preferred Stock in cash   (273,092)
Revolving line of credit (425,812) 122,918
Purchases of treasury stock (190,483)
Payments on lease liabilities (310,730) (18,812)
Net cash provided by financing activities - continuing operations 20,176,160 159,862
Net cash used by financing activities - discontinued operations (78,123)
Net cash provided by financing activities 20,176,160 81,739
Effect of currency translation 120,731 (1,198,688)
Net increase in cash, cash equivalents, and restricted cash 11,294,922 1,328,871
Cash, cash equivalents, and restricted cash at beginning of period 2,858,085 2,315,935
Cash, cash equivalents, and restricted cash at end of period 14,273,738 2,446,118
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and equivalents 12,939,493 1,572,825
Restricted cash 1,334,245 873,293
Total cash, cash equivalents, and restricted cash 14,273,738 2,446,118
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 342,268 715,722
Cash paid during the period for income taxes 75,724 162,871
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Stock issued to pay for products and/or services 428,538
Stock issued to pay notes payable 6,933,924 1,790,469
Dividends paid in equity shares 1,059,650 1,965,500
Amortization of original issue discounts on notes payable $ 757,278 $ 11,889